ESTEVE QUIMICA, S.A. By: __/s/ Andrea Oro________________________ Its: _Global Head of Business Development, APIs_ Date: __13-Feb-2023 | 13:54 PST____________ _Commercial Supply Agreement • April 27th, 2023 • Seagen Inc. • Biological products, (no disgnostic substances)
* ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. 2 pursuant to Attachment 1 hereto,...Development and Supply Agreement • April 27th, 2023 • Seagen Inc. • Biological products, (no disgnostic substances)
ContractLicense Agreement • April 27th, 2023 • Seagen Inc. • Biological products, (no disgnostic substances)
* ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. 4. REMOVAL OF FIXTURES & EQUIPMENT....Lease • April 27th, 2023 • Seagen Inc. • Biological products, (no disgnostic substances)
ContractCommercial Supply Agreement • April 27th, 2023 • Seagen Inc. • Biological products, (no disgnostic substances)
= Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. IN WITNESS WHEREOF, the Parties have...License Agreement • April 27th, 2023 • Seagen Inc. • Biological products, (no disgnostic substances)
